OXFORD IMMUNOTEC
Oxford Immunotec is a medical diagnostics company developing novel new tests for various diseases based on its innovative, patented T cell measurement technology. The company's first product is a TB test that diagnoses latent TB infection ( LTBI ) and TB disease. T-SPOT®.TB is an interferon gamma release assay ( IGRA ) which are designed to replace the century old Mantoux skin test ( TST ).
OXFORD IMMUNOTEC
Industry:
Biotechnology Health Care Health Diagnostics
Founded:
2002-01-01
Address:
Abingdon, Oxfordshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.oxfordimmunotec.com
Total Employee:
251+
Status:
Active
Contact:
+44 1235 442780
Email Addresses:
[email protected]
Total Funding:
204.48 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon WordPress Content Delivery Network Google Universal Analytics
Similar Organizations
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2016-10-12 | Immunetics | Immunetics acquired by Oxford Immunotec | 12 M USD |
| 2016-06-23 | IMUGEN, Inc. | IMUGEN, Inc. acquired by Oxford Immunotec | 22.2 M USD |
| 2014-08-05 | Boulder Diagnostics | Boulder Diagnostics acquired by Oxford Immunotec | 7.9 M USD |
Investors List
MidCap Financial
MidCap Financial investment in Post-IPO Debt - Oxford Immunotec
Invesco
Invesco investment in Venture Round - Oxford Immunotec
Wellington Partners
Wellington Partners investment in Venture Round - Oxford Immunotec
Clarus Ventures
Clarus Ventures investment in Venture Round - Oxford Immunotec
Molten Ventures
Molten Ventures investment in Venture Round - Oxford Immunotec
Spark Ventures
Spark Ventures investment in Venture Round - Oxford Immunotec
New Leaf Venture Partners
New Leaf Venture Partners investment in Venture Round - Oxford Immunotec
Kaiser Permanente Ventures
Kaiser Permanente Ventures investment in Venture Round - Oxford Immunotec
Imperial Innovations
Imperial Innovations investment in Venture Round - Oxford Immunotec
Spark Ventures
Spark Ventures investment in Series D - Oxford Immunotec
Official Site Inspections
http://www.oxfordimmunotec.com Semrush global rank: 3.96 M Semrush visits lastest month: 3.14 K
Unable to get host informations!!!
More informations about "Oxford Immunotec"
Oxford Immunotec is now Revvity
Oxford Immunotec is now Revvity. Oxford Immunotec's T-SPOT.TB test and other leading products and services are now part of Revvity's portfolio. In May, Revvity launched as a …See details»
Oxford Immunotec - Crunchbase Company Profile
Contact Email [email protected] Phone Number +44 1235 442780 Oxford Immunotec is a medical diagnostics company developing novel new tests for various diseases based on its innovative, patented T cell …See details»
Oxford Immunotec - LinkedIn
Oxford Immunotec | 11,579 followers on LinkedIn. Oxford Immunotec is now Revvity. | Oxford Immunotec is now Revvity. For more information on our transformation, please visit: update ...See details»
Oxford Immunotec Global PLC - AnnualReports.com
Oxford Immunotec Global PLC, a diagnostics company, develops and commercializes proprietary tests for the management of immune-regulated …See details»
Oxford Immunotec Company Profile - Office Locations ... - Craft
Mar 12, 2021 Oxford Immunotec has 5 employees across 22 locations. See insights on Oxford Immunotec including office locations, competitors, revenue, financials, executives, subsidiaries …See details»
About Us | Oxford Immunotec International
About Us. About Oxford Immunotec. Oxford Immunotec’s T-SPOT.TB test and other leading products and services are now part of Revvity’s portfolio.See details»
Oxford Immunotec - Seeking Alpha
Www.oxfordimmunotec.com, or the SEC's website, www.sec.gov. Investors should give careful consideration to these risks and uncertainties. Forward-looking statements contained ...See details»
Oxford Immunotec
Www.oxfordimmunotec.com, or the SEC's website, www.sec.gov. Investors should give careful consideration to these risks and uncertainties. Forward-looking statements contained ...See details»
Oxford Immunotec - Devex
Learn more about Oxford Immunotec's jobs, projects, latest news, contact information and geographical presence. Oxford Immunotec is a global, high-growth diagnostics company …See details»
Oxford Immunotec - Seeking Alpha
6 TB Screening A major global market opportunity 1 WHO. “Global Tuberculosis Report” 2017 2 Diagnostics for Tuberculosis: Global Demand and Market Potential. WHO 2006 3 Oxford …See details»
Oxford Immunotec Submits Emergency Use Authorization Request …
Mar 4, 2021 /CNW/ -- Oxford Immunotec Global PLC (Nasdaq: OXFD) (the "Company"), a global, high-growth diagnostics company, announced that today it has released the T-SPOT....See details»
Oxford Immunotec International
Brand transition. Oxford Immunotec’s T-SPOT.TB test and other leading products and services are now part of Revvity’s portfolio.See details»
PerkinElmer Completes Acquisition of Oxford Immunotec Global PLC
Mar 9, 2021 PerkinElmer, Inc., (NYSE: PKI) a global leader committed to innovating for a healthier world, today announced that the Company has completed its previSee details»
PerkinElmer to Acquire Oxford Immunotec Global PLC
Jan 7, 2021 Investors and security holders will be able to obtain free copies of the Scheme Document and Proxy Statement and other documents filed with the SEC by PerkinElmer and …See details»
Oxford Immunotec North America | TB Medical Diagnostics
About Us. About Oxford Immunotec. Oxford Immunotec’s T-SPOT.TB test and other leading products and services are now part of Revvity’s portfolio.See details»
PerkinElmer Completes Acquisition of Oxford Immunotec Global PLC
PerkinElmer Completes Acquisition of Oxford Immunotec Global PLC. WALTHAM, Mass.–(BUSINESS WIRE)–Mar. 9, 2021– PerkinElmer, Inc., (NYSE: PKI) a global leader …See details»
Oxford Immunotec - Seeking Alpha
Visiting the investor section of our website, www.oxfordimmunotec.com, or the SEC's website, www.sec.gov. Investors should give careful consideration to these risks and uncertainties. …See details»
Contact Us | Oxford Immunotec International
Introducing Revvity – Expanding the boundaries of human potential through science. All products and services previously affiliated with Oxford Immunotec are now part of Revvity.See details»
Products & Services - Oxford Immunotec North America
Introducing Revvity – Expanding the boundaries of human potential through science. All products and services previously affiliated with Oxford Immunotec are now part of Revvity.See details»